BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25587898)

  • 21. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
    van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis.
    Wu X; Chen X
    Chin Med J (Engl); 2002 Oct; 115(10):1569-72. PubMed ID: 12490113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
    Hendricks RL; Janowicz M; Tumpey TM
    J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
    Krawczyk A; Krauss J; Eis-Hübinger AM; Däumer MP; Schwarzenbacher R; Dittmer U; Schneweis KE; Jäger D; Roggendorf M; Arndt MA
    J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopathology of herpetic stromal keratitis: discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients.
    Thomas J; Rouse BT
    J Immunol; 1998 Apr; 160(8):3965-70. PubMed ID: 9558104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis.
    Banerjee K; Biswas PS; Kumaraguru U; Schoenberger SP; Rouse BT
    J Immunol; 2004 Dec; 173(12):7575-83. PubMed ID: 15585885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.
    Rousseau A; Boutolleau D; Titier K; Bourcier T; Chiquet C; Weber M; Colin J; Gueudry J; M'Garrech M; Bodaghi B; Burrel S; Agut H; Deback C; ; Labetoulle M
    Antiviral Res; 2017 Oct; 146():205-212. PubMed ID: 28939476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensory Nerve Retraction and Sympathetic Nerve Innervation Contribute to Immunopathology of Murine Recurrent Herpes Stromal Keratitis.
    Yun H; Yin XT; Stuart PM; St Leger AJ
    Invest Ophthalmol Vis Sci; 2022 Feb; 63(2):4. PubMed ID: 35103749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis.
    Xia L; Zhang S; Cao Z; Hu Y; Yang H; Wang D
    Microbes Infect; 2013 Feb; 15(2):126-39. PubMed ID: 23159245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modalities to decrease stromal herpes simplex keratitis reactivation rates.
    Sheppard JD; Wertheimer ML; Scoper SV
    Arch Ophthalmol; 2009 Jul; 127(7):852-6. PubMed ID: 19597103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of an immortalized human corneal epithelial cell line with Vero cells in the isolation of Herpes simplex virus-1 for the laboratory diagnosis of Herpes simplex keratitis.
    Athmanathan S; Reddy SB; Nutheti R; Rao GN
    BMC Ophthalmol; 2002 Apr; 2():3. PubMed ID: 11983023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpetic stromal keratitis in the absence of viral antigen recognition.
    Banerjee K; Deshpande S; Zheng M; Kumaraguru U; Schoenberger SP; Rouse BT
    Cell Immunol; 2002 Oct; 219(2):108-18. PubMed ID: 12576029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of lacrimal gland inflammation in the mouse model of herpes stromal keratitis.
    Rao P; McKown RL; Laurie GW; Suvas S
    Exp Eye Res; 2019 Jul; 184():101-106. PubMed ID: 31009613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4(+) and CD8(+) cells are key participants in the development of recurrent herpetic stromal keratitis in mice.
    Keadle TL; Morris JL; Pepose JS; Stuart PM
    Microb Pathog; 2002 Jun; 32(6):255-62. PubMed ID: 12137752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.
    Heiligenhaus A; Bauer D; Meller D; Steuhl KP; Tseng SC
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1969-74. PubMed ID: 11481259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 2000 Aug; 118(8):1030-6. PubMed ID: 10922194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice.
    Lepisto AJ; Frank GM; Xu M; Stuart PM; Hendricks RL
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3400-9. PubMed ID: 16877409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent.
    Lundberg P; Openshaw H; Wang M; Yang HJ; Cantin E
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4162-70. PubMed ID: 17724202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who (what) pays toll for the development of herpetic stromal keratitis (HSK).
    Hayashi K; Hooper LC; Hooks JJ
    Semin Ophthalmol; 2008; 23(4):229-34. PubMed ID: 18584560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of LFA-1 and ICAM-1 in the herpetic disease resulting from HSV-1 corneal infection.
    Dennis RF; Siemasko KF; Tang Q; Hendricks RL; Finnegan A
    Curr Eye Res; 1995 Jan; 14(1):55-62. PubMed ID: 7720405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.